In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Medical Services Patients & Visitors Health Library For Medical Professionals Quality About Us PhysicianLink
Text Size:  -   +  |  Print Page  |  Email Page

Lung Cancer

Non-Small Cell Lung Cancer

An Open-Label, Randomized, Phase 3 Trial of Nivolumab versus Investigator’s Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer

For additional information please contact Nurdan Ilgaz, Clinical Research Coordinator, at 859-260-6406. . 
REF# BHL-13-1162


Small Cell Lung Cancer

Phase 1b/2, Multicenter, Open-label Study of Carfilzomib, Carboplatin, and Etoposide in Subjects with Previously Untreated Extensive Stage Small-cell Lung Cancer.

For additional information please contact Heather Tudor, Clinical Research Coordinator, at 859-260-3196. 
REF# BHL-13-1129